Skip to main content

Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder and Its Treatment

  • Book
  • © 2012

Overview

  • A rich compendium that pulls together evidence from the basic and clinical neurosciences to provide an update on characteristics, comorbidity, potential causes , consequences and treatment of ADHD
  • Strong emphasis on translational research of ADHD, leading from science to evidence-based novel treatment and coping strategies
  • Offers a new paradigm for understanding ADHD
  • Contributing authors are international basic and clinical researchers
  • Includes supplementary material: sn.pub/extras

Part of the book series: Current Topics in Behavioral Neurosciences (CTBN, volume 9)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (17 chapters)

Keywords

About this book

In this volume there is a strong emphasis on translational science, with preclinical approaches suggesting new directions for development of new treatments.  Individual chapters describe how neuroimaging, neuroendocrine, genetic and behavioral studies use powerful research tools that are offering a completely new understanding of the factors that increase vulnerability to ADHD.  The clinical impact of co-morbid problems, especially obesity and substance misuse, are highlighted and explain what such problems can tell us about the etiology of ADHD, more generally.  Reviews of the pharmacology of established drug treatments for ADHD justify an exciting novel theory for their therapeutic actions and address questions about the effects of their long‑term use. 

Editors and Affiliations

  • , Dept of Neurosci, Physiol & Pharmacol, University College London, London, United Kingdom

    Clare Stanford

  • , Human Development & Applied Psychology, The Ontario Institute for Studies in Edu, Toronto, Canada

    Rosemary Tannock

Bibliographic Information

Publish with us